These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33691141)

  • 1. The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases.
    Anderson BO; Ilbawi AM; Fidarova E; Weiderpass E; Stevens L; Abdel-Wahab M; Mikkelsen B
    Lancet Oncol; 2021 May; 22(5):578-581. PubMed ID: 33691141
    [No Abstract]   [Full Text] [Related]  

  • 2. Asking the right question: implementation research to accelerate national non-communicable disease responses.
    Peters DH; Peters MA; Wickramasinghe K; Osewe PL; Davidson PM
    BMJ; 2019 May; 365():l1868. PubMed ID: 31110030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National action plans to tackle NCDs: role of stakeholder network analysis.
    Hunter RF; Wickramasinghe K; Ergüder T; Bolat A; Arı HO; Yıldırım HH; Ursu P; Robinson G; Breda J; Mikkelsen B; Connolly P; Clarke M; Kee F
    BMJ; 2019 May; 365():l1871. PubMed ID: 31110055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Road to Addressing Noncommunicable Diseases and Cancer in Global Health Policy.
    Catoe H; Jarvis J; Gupta S; Ginsburg O; de Lima Lopes G
    Am Soc Clin Oncol Educ Book; 2017; 37():29-33. PubMed ID: 28561645
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-communicable disease (NCD) corners in public sector health facilities in Bangladesh: a qualitative study assessing challenges and opportunities for improving NCD services at the primary healthcare level.
    Rawal LB; Kanda K; Biswas T; Tanim MI; Poudel P; Renzaho AMN; Abdullah AS; Shariful Islam SM; Ahmed SM
    BMJ Open; 2019 Oct; 9(10):e029562. PubMed ID: 31594874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using economic evidence to support policy decisions to fund interventions for non-communicable diseases.
    Bertram M; Banatvala N; Kulikov A; Belausteguigoitia I; Sandoval R; Hennis A; Webb D; Tarlton D
    BMJ; 2019 May; 365():l1648. PubMed ID: 31110025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capacity Building and Innovation in Caring for Non-communicable Diseases in Maternal Global Health: The Example of Haiti.
    Malhamé I; Pilote L; Destiné R; Israel K; von Oettingen JE;
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1479-1481. PubMed ID: 31395372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive primary health care and non-communicable diseases management: a case study of El Salvador.
    Jimenez Carrillo M; León García M; Vidal N; Bermúdez K; De Vos P
    Int J Equity Health; 2020 Apr; 19(1):50. PubMed ID: 32252764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. False dichotomies in global health: the need for integrative thinking.
    Frenk J; Gómez-Dantés O
    Lancet; 2017 Feb; 389(10069):667-670. PubMed ID: 27771016
    [No Abstract]   [Full Text] [Related]  

  • 10. Strengthening management of non-communicable diseases in primary care, Malawi: A short report.
    Mailosi A; Miller C; Hodge C; Msimuko S
    Afr J Prim Health Care Fam Med; 2021 Dec; 13(1):e1-e3. PubMed ID: 34879698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community and health staff perceptions on non-communicable disease management in El Salvador's health system: a qualitative study.
    Vidal N; León-García M; Jiménez M; Bermúdez K; De Vos P
    BMC Health Serv Res; 2020 May; 20(1):474. PubMed ID: 32460769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergies between Communicable and Noncommunicable Disease Programs to Enhance Global Health Security.
    Kostova D; Husain MJ; Sugerman D; Hong Y; Saraiya M; Keltz J; Asma S
    Emerg Infect Dis; 2017 Dec; 23(13):S40-6. PubMed ID: 29155655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social determinants and non-communicable diseases: time for integrated action.
    Marmot M; Bell R
    BMJ; 2019 Jan; 364():l251. PubMed ID: 30692093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Committing to implementation research for health systems to manage and control non-communicable diseases.
    Marten R; Mikkelsen B; Shao R; Dal Zennaro L; Berdzuli N; Fernando T; Hammerich A; Hennis A; Shin HR; Shongwe S; Ghaffar A
    Lancet Glob Health; 2021 Feb; 9(2):e108-e109. PubMed ID: 33357502
    [No Abstract]   [Full Text] [Related]  

  • 15. NCD Research in the Post-2015 Global Health Agenda: Perspectives from the NHLBI Strategic Vision.
    Mensah GA
    Glob Heart; 2016 Dec; 11(4):479-483. PubMed ID: 27938847
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19, children and non-communicable diseases: translating evidence into action.
    Bhutta ZA; Hauerslev M; Farmer M; Lewis-Watts L
    Arch Dis Child; 2021 Feb; 106(2):141-142. PubMed ID: 33051217
    [No Abstract]   [Full Text] [Related]  

  • 17. Building on the HIV platform: tackling the challenge of noncommunicable diseases among persons living with HIV.
    El-Sadr WM; Goosby E
    AIDS; 2018 Jul; 32 Suppl 1():S1-S3. PubMed ID: 29952785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in policy reforms for non-communicable diseases: the case of diabetes in Kenya.
    Shiroya V; Neuhann F; Müller O; Deckert A
    Glob Health Action; 2019; 12(1):1611243. PubMed ID: 31117896
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergies in the fights against HIV/AIDS and against noncommunicable diseases in Africa.
    Milleliri JM
    Med Sante Trop; 2018 Nov; 28(4):341-342. PubMed ID: 30799813
    [No Abstract]   [Full Text] [Related]  

  • 20. Process evaluation of enhancing primary health care for non-communicable disease management in Malaysia: Uncovering the fidelity & feasibility elements.
    Low LL; A B Rahim FI; Hamzah NAR; Ismail MS
    PLoS One; 2021; 16(1):e0245125. PubMed ID: 33428645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.